ADVERTISEMENT
Why India’s Diagnostic Chains Are Losing Pricing Power
Revenue growth of listed diagnostic companies is slowing amid stiff competition from their peers in the unorganised space.
09 Apr 2019, 02:27 PM IST
Even as Metropolis Healthcare Ltd. launched its initial public offering earlier this month, revenue growth of listed diagnostic companies is slowing amid stiff competition from their unorganised peers—comprising 85-90 percent of the market.The challenge for listed players, according to A Velumani, the promoter and chief executive officer of Thyrocare Technologies Ltd., is the costs related to compliance and regulations, which unorgan...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT